PBH vs. IPAR, HLF, USNA, NUS, NATR, MED, VERU, EL, VTRS, and UTHR
Should you be buying Prestige Consumer Healthcare stock or one of its competitors? The main competitors of Prestige Consumer Healthcare include Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Viatris (VTRS), and United Therapeutics (UTHR).
Prestige Consumer Healthcare (NYSE:PBH) and Inter Parfums (NASDAQ:IPAR) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, community ranking, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.
In the previous week, Inter Parfums had 5 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 6 mentions for Inter Parfums and 1 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 1.85 beat Inter Parfums' score of 0.58 indicating that Prestige Consumer Healthcare is being referred to more favorably in the media.
Prestige Consumer Healthcare has a net margin of 18.60% compared to Inter Parfums' net margin of 10.50%. Inter Parfums' return on equity of 15.85% beat Prestige Consumer Healthcare's return on equity.
Prestige Consumer Healthcare has a beta of 0.53, indicating that its stock price is 47% less volatile than the S&P 500. Comparatively, Inter Parfums has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500.
Prestige Consumer Healthcare presently has a consensus target price of $91.25, indicating a potential upside of 41.89%. Inter Parfums has a consensus target price of $178.67, indicating a potential upside of 49.16%. Given Inter Parfums' stronger consensus rating and higher probable upside, analysts plainly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.
Prestige Consumer Healthcare received 38 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.70% of users gave Prestige Consumer Healthcare an outperform vote while only 64.32% of users gave Inter Parfums an outperform vote.
100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 55.6% of Inter Parfums shares are owned by institutional investors. 1.6% of Prestige Consumer Healthcare shares are owned by insiders. Comparatively, 43.9% of Inter Parfums shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Prestige Consumer Healthcare has higher earnings, but lower revenue than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.
Summary
Inter Parfums beats Prestige Consumer Healthcare on 12 of the 18 factors compared between the two stocks.
Get Prestige Consumer Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PBH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Prestige Consumer Healthcare Competitors List
Related Companies and Tools
